<DOC>
	<DOCNO>NCT02344680</DOCNO>
	<brief_summary>In study investigator determine risk factor liver fibrosis among HIV-HBV co-infected patient Lusaka , Zambia , assess long-term effectiveness antiretroviral drug prevention and/or reduction liver disease .</brief_summary>
	<brief_title>Liver Fibrosis Zambian HIV-HBV Co-infected Patients</brief_title>
	<detailed_description>Among HIV-infected individual Africa , liver disease neglect area investigation anticipate become increasingly common patient live long due antiretroviral therapy . In currently approve active research study take place Lusaka Urban district - HIV/HBV co-infection IeDEA-SA ( NCT02060162 , clinicaltrials.gov ) - 800 consecutive HIV-infected adult screen possible cause liver disease 12 % diagnose chronic hepatitis B virus ( HBV ) co-infection . HBV co-infected patient likely evidence liver disease ; however , ascertainment critical long-term outcome HIV-HBV patient part study . Building preliminary result address need study HIV-HBV long duration follow-up , current protocol focus exclusively Zambian HIV-HBV patient . In proposed study , investigator determine risk factor liver disease among Zambian HIV-HBV co-infected patient , assess long-term effectiveness Ministry Health ( MOH ) -recommended antiretroviral drug prevention and/or reduction HIV-HBV liver disease . This study provide useful clinical epidemiologic information health policymakers Zambia throughout region may lead improvement care HIV-HBV patient . Further , strengthen collaboration Zambian institution strengthen local capacity HBV diagnosis management .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Hepatitis , Alcoholic</mesh_term>
	<mesh_term>Hepatitis D</mesh_term>
	<mesh_term>Anti-HIV Agents</mesh_term>
	<criteria>Age 18 year older HIVinfected HBVinfected , define single positive HBsAg assay Na√Øve antiretroviral therapy currently participate HIV/HBV coinfection IeDEASA Unable unwilling provide inform consent Planning relocate Lusaka district</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>